The World Boxing Council has cleared boxer Conor Bean of all responsibility for the positive test for clomiphene that caused the suspension of his bout, scheduled for October 2022, against Chris Eubanks Jr. For the opposite sample collected from the controls conducted in between July and September
The positive test revealed clomiphene, a fertility enhancer for women that increases testosterone levels in men. Bean has always maintained that he has never taken banned substances knowingly or intentionally. His team provided a detailed report of his diet in the days before the controls in early February to say it may be behind the opposite result.
Read also:
The WBC consulted a nutritionist who endorsed the theory that Conor Bean’s higher egg consumption during the observation period was a reasonable explanation. Thus, the WBC said in a statement “there was no conclusive evidence that Connor Penn intentionally or knowingly took clomiphene.”
The WBC returned the British boxer to the world rankings. “Mr. Benn’s position in the WBC rankings will depend solely on his merits and the usual factors which the WBC Rankings Committee applies to eligible boxers.”
Despite this decision, Conor Bean’s case is still under investigation by the UK Anti-Doping Agency and the British Boxing Board of Control. Until this process is complete, Benn Boxing will not be licensed in the UK, but could be based in another country. Penn’s last fight was in April 2022, when he defeated Chris Van Heerden by knockout in his WBA welterweight title defense.
The World Boxing Council also announced that it would report this case to the World Anti-Doping Agency (WADA) due to its concern about “false positives resulting from eating contaminated food”.
Amelia Kensington is a contributor to Mediarunsearch.co.uk, covering a wide range of topics including news, politics, business, technology, sport, entertainment, and lifestyle. She focuses on delivering clear, balanced reporting and useful information that helps readers stay informed about current events and emerging developments. Her work highlights stories that matter to everyday audiences, presenting complex topics in an accessible and engaging way while maintaining a strong commitment to accuracy and relevance.